Swedish Cancer Institute (SCI) — Seattle, Washington

Swedish Cancer Institute (SCI) is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute (SCI) has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Solid Tumor, Adult, Breast Cancer, Non Small Cell Lung Cancer.

Sponsors: CytomX Therapeutics, Eli Lilly and Company, Sermonix Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute (SCI)?

Swedish Cancer Institute (SCI) has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute (SCI) conducted?

Swedish Cancer Institute (SCI) has 4 clinical trials on record, with 3 currently active. Their work covers Solid Tumor, Adult, Breast Cancer, Non Small Cell Lung Cancer.

Is Swedish Cancer Institute (SCI) accredited by Crixeo Health?

Swedish Cancer Institute (SCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute (SCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.